Catalyst Wire Dossier Catalyst Wire Dossier

Levofloxacin 0.5% ophthalmic solution

levofloxacin
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Levofloxacin 0.5% ophthalmic solution, covering 2007-11-29 to 2007-11-29. Get the full timeline:

Most recent: Clinical Trial Update: Study of Efficacy of Levofloxacin 0.5% Ophthalmic Solution Administered Three Times a Day for Bacterial Conjunctivitis [Phase 2, Phase 3]

See pricing